ScholarIQanswers from OpenAlex
Providence College
InstitutionResearch output, impact & collaborations
Providence College is a institution indexed in ScholarIQ from OpenAlex.
What is known about Providence College?
ScholarIQrecord summary
Providence College is a research organisation in Providence, US. OpenAlex records 33,868 works and 2,427,053 citations for it. 7,433 researchers list it as their most recent affiliation.
How many works does Providence College have?
ScholarIQindexed works
Providence College has 33,868 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Providence College have?
ScholarIQcitation count
Providence College has 2,427,053 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Providence College?
ScholarIQresearcher count
Providence College has 7,433 researchers in the ScholarIQ index.
What is the average h-index at Providence College?
ScholarIQavg h-index
Providence College has an average h-index of 53.8 in OpenAlex.
What is the ROR of Providence College?
ScholarIQror
The ROR for Providence College is on the source record.
What is the OpenAlex record for Providence College?
ScholarIQopenalex
The OpenAlex for Providence College is on the source record.
Who are the most-cited researchers behind Providence College?
ScholarIQtop researchers by citations
5
Ivan W. Miller · Child and Adolescent Psychosocial and Emotional Development
267 works16,201 citationsWhat are the most-cited papers on Providence College?
ScholarIQmost cited works
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
Kathleen N. Moore, Nicoletta Colombo, Giovanni Scambia, Byoung‐Gie Kim, Ana Oaknin, Michael Friedländer, Alla Lisyanskaya, Anne Floquet, Alexandra Léary, Gabe S. Sonke, Charlie Gourley, Susana Banerjee, Amit M. Oza, Antonio González-Martı́n, Carol Aghajanian, William H. Bradley, Cara Mathews, Joyce F. Liu, Elizabeth Lowe, Ralph Bloomfield, Paul DiSilvestro
Integrated genomic and molecular characterization of cervical cancer
Robert D. Burk, Zigui Chen, Saller Cf, Katherine Tarvin, André L. Carvalho, Cristovam Scapulatempo-Neto, Henrique C. Silveira, José H. Fregnani, Chad J. Creighton, Matthew L. Anderson, Patricia Castro, Sophia S. Wang, C Yau, Christopher Benz, A. Gordon Robertson, Karen Mungall, Lynette Lim, Reanne Bowlby, Sara Sadeghi, Denise Brooks, Payal Sipahimalani, Richard Mar, Ally Ai, Amanda Clarke, Andrew J. Mungall, Angela Tam, Darlene Lee, Eric Chuah, Jacqueline E. Schein, Kane Tse, Katayoon Kasaian, Yussanne Ma, Marco A. Marra, Michael Mayo, Miruna Balasundaram, Nina Thiessen, Noreen Dhalla, Rebecca Carlsen, Richard A. Moore, Robert A. Holt, Steven J.M. Jones, Tina Wong, Angeliki Pantazi, Michael Parfenov, Raju Kucherlapati, Angela Hadjipanayis, J G Seidman, Melanie Kucherlapati, Xiaojia Ren, Andrew W. Xu, Lixing Yang, Peter J. Park, So Lee, Brenda Rabeno, Lori Huelsenbeck-Dill, Mark Borowsky, Mark Cadungog, Mary Iacocca, Nicholas Petrelli, Patricia Swanson, Akinyemi I. Ojesina, Bradley A. Murray, Hailei Zhang, Andrew D. Cherniack, Carrie Sougnez, Chandra Sekhar Pedamallu, Lee Lichtenstein, M. Meyerson, Michael S. Noble, David I. Heiman, Doug Voet, Getz Gs, Gordon Saksena, Jaegil Kim, Juliann Shih, Juok Cho, Michael S. Lawrence, Nils Gehlenborg, Pei Lin, Rameen Beroukhim, Scott Frazer, Stacey B. Gabriel, Steven E. Schumacher, Xuan Le, George Sandusky, Sally N. Adebamowo, Teniola Akeredolu, Clement Adebamowo, Sheila M. Reynolds, Ilya Shmulevich, Candace Shelton, Daniel Crain, David Mallery, Erin Curley, Johanna Gardner, Robert Penny, Scott Morris, Troy Shelton, J B Liu, Laxmi Lolla
A Controlled Trial of Erenumab for Episodic Migraine
Peter J. Goadsby, Uwe Reuter, Yngve Hallström, Gregor Broessner, Jo Bonner, Feng Zhang, Sandhya Sapra, Hernàn Picard, Daniel D. Mikol, Robert Lenz
Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer
Robert L. Coleman, Gini F. Fleming, Mark F. Brady, Elizabeth M. Swisher, Karina Dahl Steffensen, Michael Friedländer, Aikou Okamoto, Kathleen N. Moore, Noa Ben-Baruch, Theresa L. Werner, Noelle Cloven, Ana Oaknin, Paul DiSilvestro, Mark A. Morgan, Joo‐Hyun Nam, Charles A. Leath, Shibani Nicum, Andrea R. Hagemann, Ramey D. Littell, David Cella, Sally Baron‐Hay, Jesús García-Donás, Mika Mizuno, Katherine M. Bell‐McGuinn, Danielle Sullivan, Bruce Allen Bach, Sudipta Bhattacharya, Christine K. Ratajczak, Peter Ansell, Minh H. Dinh, Carol Aghajanian, Michael A. Bookman
A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass
Richard G. Moore, D. Scott McMeekin, Amy Brown, Paul DiSilvestro, Michael Craig Miller, W. Jeffrey Allard, W Gajewski, Robert J. Kurman, Robert C. Bast, Steven J. Skates
How much of the research on Providence College is open access?
ScholarIQopen access share
75%OPEN ACCESS